Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management

an intensive care unit? For a short explanation of why the committee made this recommendation for research, see the rationale section on intracranial hypertension. Full details of the evidence and the committee's discussion are in evidence review I: detecting intracranial hypertension and evidence review J: managing intracranial hypertension. 10 Intra-arterial therapies to manage delayed cerebral ischaemia What is the impact of intra-arterial therapies to manage delayed cerebral ischaemia on outcome in people with aneurysmal subarachnoid haemorrhage? For a short explanation of why the committee made this recommendation for research, see the rationale section on delayed cerebral ischaemia. Full details of the evidence and the committee's discussion are in evidence review F: management of delayed cerebral ischaemia. 11 Vasopressors to manage delayed cerebral ischaemia What is the clinical and cost effectiveness of vasopressors to manage delayed cerebral ischaemia in people with aneurysmal subarachnoid haemorrhage? For a short explanation of why the committee made this recommendation for research, see the rationale section on delayed cerebral ischaemia. Full details of the evidence and the committee's discussion are in evidence review F: management of delayed cerebral ischaemia. 12 Blood pressure targets What is the clinical and cost effectiveness of a lower blood pressure treatment
